Dominic Spinella, Ph.D.

Dominic has over 25 years of experience in drug research and development and the discipline of Translational Medicine. He has been an executive leader at Chugai Biopharmaceuticals USA, where he was Vice President of Exploratory Research; at Pfizer where he served as head of Translational Medicine for the Oncology division; and at Amgen where he was Executive Director of Medical Sciences and head of Biomarkers and Diagnostics. A former professor of Medicine and Immunology at the University of Tennessee College of Medicine and Howard Hughes postdoctoral fellow at Washington University School of Medicine in St. Louis, he also served on several national and international cancer biomarker development bodies.